IFP Advisors’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.59K | Sell |
370
-15
| -4% | -$343 | ﹤0.01% | 3550 |
|
|
2026
Q1 | $8.48K | Sell |
385
-22
| -5% | -$383 | ﹤0.01% | 3233 |
|
|
2025
Q4 | $4.8K | Buy |
407
+85
| +26% | +$1.09K | ﹤0.01% | 3437 |
|
|
2025
Q3 | $5.1K | Buy |
+322
| New | +$4.67K | ﹤0.01% | 3238 |
|
|
2025
Q2 | – | Sell |
-559
| Closed | -$6.3K | – | 2163 |
|
|
2025
Q1 | $7.96K | Buy |
559
+163
| +41% | +$2.71K | ﹤0.01% | 2656 |
|
|
2024
Q4 | $7.2K | Sell |
396
-1,198
| -75% | -$23.3K | ﹤0.01% | 2670 |
|
|
2024
Q3 | $32.4K | Sell |
1,594
-120
| -7% | -$2.45K | ﹤0.01% | 1925 |
|
|
2024
Q2 | $38.7K | Hold |
1,714
| – | – | ﹤0.01% | 1779 |
|
|
2024
Q1 | $45K | Sell |
1,714
-177
| -9% | -$5.04K | ﹤0.01% | 1632 |
|
|
2023
Q4 | $59.6K | Sell |
1,891
-341
| -15% | -$9.26K | ﹤0.01% | 1475 |
|
|
2023
Q3 | $62.6K | Buy |
2,232
+626
| +39% | +$21.5K | ﹤0.01% | 1460 |
|
|
2023
Q2 | $59.2K | Buy |
1,606
+191
| +13% | +$5.83K | ﹤0.01% | 1534 |
|
|
2023
Q1 | $11.5K | Buy |
1,415
+141
| +11% | +$4.64K | ﹤0.01% | 2234 |
|
|
2022
Q4 | $18K | Sell |
1,274
-3,336
| -72% | -$100K | ﹤0.01% | 2960 |
|
|
2022
Q3 | $60K | Buy |
4,610
+382
| +9% | +$12.6K | ﹤0.01% | 2226 |
|
|
2022
Q2 | $55K | Hold |
4,228
| – | – | ﹤0.01% | 2096 |
|
|
2022
Q1 | $55K | Buy |
4,228
+2,672
| +172% | +$83.6K | ﹤0.01% | 2096 |
|
|
2021
Q4 | $54K | Buy |
1,556
+1,059
| +213% | +$33K | ﹤0.01% | 1518 |
|
|
2021
Q3 | $16K | Sell |
497
-17
| -3% | -$550 | ﹤0.01% | 2079 |
|
|
2021
Q2 | $18K | Buy |
514
+97
| +23% | +$3.21K | ﹤0.01% | 1970 |
|
|
2021
Q1 | $12K | Buy |
417
+311
| +293% | +$8.28K | ﹤0.01% | 2051 |
|
|
2020
Q4 | $3K | Sell |
106
-2,048
| -95% | -$48.7K | ﹤0.01% | 2482 |
|
|
2020
Q3 | $44K | Buy |
2,154
+27
| +1% | +$521 | ﹤0.01% | 1331 |
|
|
2020
Q2 | $32K | Sell |
2,127
-164
| -7% | -$2.07K | ﹤0.01% | 1396 |
|
|
2020
Q1 | $24K | Buy |
2,291
+2,110
| +1,166% | +$30.4K | ﹤0.01% | 1410 |
|
|
2019
Q4 | $2K | Sell |
181
-1,850
| -91% | -$30.7K | ﹤0.01% | 2488 |
|
|
2019
Q3 | $28K | Buy |
+2,031
| New | +$33K | ﹤0.01% | 1614 |
|
|
2019
Q1 | $40K | Sell |
1,120
-2,015
| -64% | -$73.3K | 0.01% | 1051 |
|
|
2018
Q4 | $87K | Sell |
3,135
-911
| -23% | -$28.8K | 0.01% | 1271 |
|
|
2018
Q3 | $160K | Sell |
4,046
-362
| -8% | -$15.8K | 0.01% | 1203 |
|
|
2018
Q2 | $196K | Buy |
4,408
+1,336
| +43% | +$66.5K | 0.01% | 1074 |
|
|
2018
Q1 | $154K | Hold |
3,072
| – | – | 0.01% | 1114 |
|
|
2017
Q4 | $154K | Sell |
3,072
-8,905
| -74% | -$466K | 0.01% | 1121 |
|
|
2017
Q3 | $606K | Buy |
11,977
+5,903
| +97% | +$278K | 0.02% | 614 |
|
|
2017
Q2 | $230K | Sell |
6,074
-12,997
| -68% | -$513K | 0.01% | 1045 |
|
|
2017
Q1 | $734K | Sell |
19,071
-1,997
| -9% | -$60.1K | 0.03% | 527 |
|
|
2016
Q4 | $465K | Buy |
21,068
+12,562
| +148% | +$258K | 0.02% | 645 |
|
|
2016
Q3 | $136K | Sell |
8,506
-2,392
| -22% | -$27.3K | 0.01% | 1190 |
|
|
2016
Q2 | $90K | Buy |
10,898
+9,778
| +873% | +$87.1K | 0.01% | 1404 |
|
|
2016
Q1 | $40K | Sell |
1,120
-9,792
| -90% | -$49.2K | 0.01% | 1051 |
|
|
2015
Q4 | $58K | Buy |
+10,912
| New | +$69.7K | ﹤0.01% | 1508 |
|
Other funds holding CC
CCPM
IFP Advisors's CC Position: Q2 2026 in Review
IFP Advisors reduced its Chemours (CC) stake by 3.9% in Q2 2026, selling an estimated $343 and leaving 370 shares worth $7.59K. The position accounts for ﹤0.01% of the portfolio, ranked #3550.
IFP Advisors first reported a position in CC in Q4 2015 and has held it in 41 quarters since. The position peaked at $734K in Q1 2017. 470 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- IFP Advisors held 370 shares of Chemours worth $7.59K as of Q2 2026.
- IFP Advisors sold 15 Chemours shares in Q2 2026, an estimated $343.
- Chemours made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3550 holding.
- IFP Advisors first reported a position in Chemours in Q4 2015 and has held it in 41 quarters since.
- IFP Advisors's Chemours position peaked at $734K in Q1 2017.
- 470 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.